Aion Therapeutic Inc.
ANTCF
OTC PK
$0.0077
-$0.002-20.68%
Volume100
06/21/2022 1:34PM Eastern
Quotes delayed
| 01/31/2022 | 10/31/2021 | 07/31/2021 | 04/30/2021 | 01/31/2021 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -35.00K | 15.20K |
| Gross Profit | -- | -- | -- | 35.00K | -15.20K |
| SG&A Expenses | 226.70K | 332.60K | 310.00K | 811.90K | 344.40K |
| Depreciation & Amortization | 13.80K | 18.40K | 18.80K | 18.40K | 19.30K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 240.50K | 351.00K | 328.80K | 795.30K | 378.90K |
| Operating Income | -240.50K | -351.00K | -328.80K | -795.30K | -378.90K |
| Income Before Tax | -513.90K | -637.80K | -607.80K | -4.18M | -1.24M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -513.90K | -637.80K | -607.80K | -4.18M | -1.24M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -513.90K | -637.80K | -607.80K | -4.18M | -1.24M |
| EBIT | -240.50K | -351.00K | -328.80K | -795.30K | -378.90K |
| EBITDA | -226.70K | -332.60K | -310.00K | -776.90K | -359.70K |
| EPS Basic | 0.00 | 0.00 | 0.00 | -0.04 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | -0.04 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| Average Basic Shares Outstanding | 141.80M | 141.80M | 134.23M | 117.72M | 109.44M |
| Average Diluted Shares Outstanding | 141.80M | 141.80M | 134.23M | 117.72M | 109.44M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
